<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03584412</url>
  </required_header>
  <id_info>
    <org_study_id>236730</org_study_id>
    <secondary_id>PDF-2015-08-059</secondary_id>
    <nct_id>NCT03584412</nct_id>
  </id_info>
  <brief_title>OPEN Feasibility Study</brief_title>
  <official_title>Feasibility Randomized-Controlled Trial of Online Acceptance and Commitment Therapy for Painful Peripheral Neuropathy in People Living With HIV: The OPEN Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chelsea and Westminster NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current trial will explore the feasibility of a larger efficacy trial to test a newly&#xD;
      developed form of online CBT called Acceptance and Commitment Therapy (which we have called&#xD;
      &quot;ACT OPEN&quot;) for people with HIV and painful peripheral neuropathy. Participants will be&#xD;
      recruited from HIV clinics in London, UK. Participants will be randomly chosen to receive the&#xD;
      new ACT OPEN treatment right away or after waiting for 5 months. The treatment lasts for 8&#xD;
      weeks. Participants will complete self-report questionnaires to assess pain, functioning, and&#xD;
      mood at the beginning of the study and 8 weeks and five months later.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The human immunodeficiency virus (HIV) is a major health problem in the United Kingdom and&#xD;
      worldwide. Neuropathic pain in the feet related to peripheral neuropathy is one of the most&#xD;
      common symptoms associated with HIV. This pain is difficult to treat and medications are not&#xD;
      effective. Chronic pain in people with HIV is related to higher levels of disability and poor&#xD;
      quality of life.&#xD;
&#xD;
      Psychological treatments like cognitive behaviour therapy (CBT) can improve quality of life&#xD;
      for people with chronic pain in general (not HIV-related), and there have been efforts to&#xD;
      provide more accessible versions of CBT over the Internet. However, it is not known whether&#xD;
      Internet-based CBT is helpful for people with HIV and chronic pain.&#xD;
&#xD;
      The current trial will explore the feasibility of a newly developed form of online CBT called&#xD;
      Acceptance and Commitment Therapy (which we have called &quot;ACT OPEN&quot;) for people with HIV and&#xD;
      painful peripheral neuropathy. Participants will be recruited from HIV clinics in London, UK.&#xD;
      Participants will be randomly chosen to receive the new ACT OPEN treatment right away or&#xD;
      after waiting for 5 months. The treatment lasts for 8 weeks. Participants will complete&#xD;
      self-report questionnaires to assess pain, functioning, and mood at the beginning of the&#xD;
      study and 8 weeks and five months later.&#xD;
&#xD;
      The purpose of this study is to examine the feasibility of a larger trial evaluating the&#xD;
      impact of online ACT for people with HIV and chronic pain in their feet. Key feasibility&#xD;
      parameters that will be evaluated will include an estimate of the recruitment and retention&#xD;
      rates, treatment completion rate and satisfaction, and an estimate of the effect size of&#xD;
      changes in standard pain outcome measures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">July 9, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly assigned to the ACT OPEN treatment condition immediately or following a 5 month wait using a 2:1 randomisation ratio (2: immediately; 1: waiting list control).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment Rate</measure>
    <time_frame>Baseline</time_frame>
    <description>Proportion of participants randomised relative to total trial referrals</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention Rate</measure>
    <time_frame>8 weeks post-randomisation</time_frame>
    <description>Proportion of participants who complete follow-up questionnaires</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Completion Rate</measure>
    <time_frame>8 weeks following receipt of treatment</time_frame>
    <description>We expect 70% of participants to complete at least 8/12 ACT OPEN sessions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Satisfaction</measure>
    <time_frame>8 weeks following receipt of treatment</time_frame>
    <description>Total score on the Client Satisfaction Questionnaire (range: 8-32; higher scores reflect greater satisfaction)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Data Completeness</measure>
    <time_frame>Baseline</time_frame>
    <description>Proportion of missing items on individual questionnaires</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Other Treatments Accessed</measure>
    <time_frame>8 weeks post-randomisation</time_frame>
    <description>Self-reported frequency of use of other treatments (e.g., medical, complimentary, etc)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient's impression of overall change during treatment</measure>
    <time_frame>8 weeks following receipt of treatment</time_frame>
    <description>Score on single item Patient Global Impression of Change Rating (range: 1 (very much improved) to 7 (very much worse))</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Interference</measure>
    <time_frame>8 weeks post-randomisation</time_frame>
    <description>Brief Pain Inventory average of pain interference subscale items score (range 0-10; higher scores reflect greater pain interference)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social and Occupational Functioning</measure>
    <time_frame>8 weeks post-randomisation</time_frame>
    <description>Work and Social Adjustment Scale Total Score (range: 0-40; higher scores reflect greater impairment in social and occupational functioning)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Symptoms</measure>
    <time_frame>8 weeks post-randomisation</time_frame>
    <description>PHQ-9 Total Score (range: 0-27; higher scores reflect more severe depression symptoms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Acceptance</measure>
    <time_frame>8 weeks post-randomisation</time_frame>
    <description>Chronic Pain Acceptance Questionnaire--8 Item Version Total Score (range: 0-48; higher scores reflect greater acceptance)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>8 weeks post-randomisation</time_frame>
    <description>Average of the Brief Pain Inventory pain intensity items (range: 0-10; higher scores reflect more intense pain)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>HIV Neuropathy</condition>
  <arm_group>
    <arm_group_label>ACT OPEN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acceptance and Commitment Therapy Online for Painful Peripheral Neuropathy (ACT OPEN).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting List Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants in this condition will not receive any change to their usual treatment for a period of 5 months, after which they will be given access to complete the ACT OPEN treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ACT OPEN</intervention_name>
    <description>Participants will access the ACT OPEN treatment through a secure online platform. Each session consists of brief videos and audio recordings that provide information about pain and guide participants through experiential exercises (e.g., mindfulness, values clarification, goal-setting). Participants will respond to questions assessing their experiences during the session and their progress using online messaging and/or brief telephone calls according to their preference. Therapists will provide individualised feedback. ACT OPEN consists of 12 sessions over 6 weeks. Participants will be given two further weeks to finish any uncompleted sessions, or to complete additional sessions (up to four) as agreed with their therapist.</description>
    <arm_group_label>ACT OPEN</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Waiting list control</intervention_name>
    <description>Participants will receive their usual treatment for 5 months, after which they will complete ACT OPEN as described. A waiting list control was chosen as there is no clearly credible active psychotherapy to serve as the comparator in this context, particularly in light of high drop-out rates in two previous studies of CBT for pain in HIV. Providing the online treatment without therapist support may appear to be a logical comparison group instead of a waitlist control. However, there is evidence that therapist support is a key component of online CBT and, therefore, without this support it may not represent a credible treatment against which to judge the full treatment. In the context of the feasibility aims of this trial these reasons, the use of a waiting list control is thus justified.</description>
    <arm_group_label>Waiting List Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults aged 18 years or older living with HIV.&#xD;
&#xD;
          -  Positive screen for peripheral sensory neuropathy, as indicated by the presence of&#xD;
             self-reported bilateral foot pain in a symmetrical distribution (Woldeamanuel et al.,&#xD;
             2016).&#xD;
&#xD;
          -  Positive screen for symptoms of neuropathic pain in the feet, as indicated by a score&#xD;
             of 3 or more on the patient reported outcomes section of the DN4 Neuropathic Pain&#xD;
             Interview (Bouhassira et al., 2005; Bouhassira, Lant√©ri-Minet, Attal, Laurent, &amp;&#xD;
             Touboul, 2008)&#xD;
&#xD;
          -  Pain in the feet present most days for at least 3 months.&#xD;
&#xD;
          -  Average pain intensity over the past week of at least 4 on a scale from 0 (no pain) to&#xD;
             10 (pain as bad as you can imagine) (Zelman, Dukes, Brandenburg, Bostrom, &amp; Gore,&#xD;
             2005).&#xD;
&#xD;
          -  Average interference of pain with daily activities over the past 3 months is at least&#xD;
             4 on a scale ranging from 0 (no interference) to 10 (unable to carry on any&#xD;
             activities) (Von Korff, Ormel, Keefe, &amp; Dworkin, 1992).&#xD;
&#xD;
          -  At least moderate symptoms of depression in the past 2 weeks, as indicated by a score&#xD;
             of at least 10 on the PHQ-9 (Kroenke et al., 2001).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe symptoms of depression, as indicated by a PHQ-9 score of 23 or greater.&#xD;
&#xD;
          -  Active suicidal ideation, as reflected by a score of 2 or greater on the PHQ-9 item 9&#xD;
             and current intent or plan to self-harm.&#xD;
&#xD;
          -  A positive screen of self-reported alcohol or other substance abuse in the past 3&#xD;
             months as reflected by an ASSIST-Lite score of at least 3 for alcohol or at least 2&#xD;
             for other substances, including misuse of prescribed opioids.&#xD;
&#xD;
          -  Presence of any other severe psychiatric disorder (e.g., schizophrenia, bipolar&#xD;
             disorder, post-traumatic stress disorder) that is currently unstable or poorly&#xD;
             controlled and likely to interfere with treatment engagement, as judged by a clinical&#xD;
             psychologist conducting the screening.&#xD;
&#xD;
          -  Currently receiving another form of regular psychotherapy (i.e., weekly appointments);&#xD;
             involvement in psychotherapy or counselling appointments occurring less than weekly&#xD;
             will be permitted.&#xD;
&#xD;
          -  Changes to medications for mood and pain for the last 6 weeks.&#xD;
&#xD;
          -  Major surgical procedure for any reason planned within the next 5 months.&#xD;
&#xD;
          -  Unable to complete study procedures in English&#xD;
&#xD;
          -  Unwilling to commit approximately 1-2 hours per week to complete the treatment and to&#xD;
             do so over the Internet (note: access to a tablet/wifi will be provided for otherwise&#xD;
             eligible participants who do not have such access; therefore, lack of internet access&#xD;
             will not be an exclusion criterion)&#xD;
&#xD;
          -  Unable to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Whitney Scott, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Whitney Scott</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chelsea and Westminster Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guy's and St Thomas' Hospital NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>June 18, 2018</study_first_submitted>
  <study_first_submitted_qc>June 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2018</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

